References and Publications

1. Viral Inactivation of Pooled Human Platelet Lysate Using Gamma Irradiation. ISCT Poster Presentation, Madison, 2019
2. Modeling biological and economic uncertainty on cell therapy manufacturing the choice of culture media supplementation. Regenerative Medicine. 13(8), 917–933 (2018)
3. ​Flow Preservation of Umbilical Vein for Autologous Shunt and Cardiovascular Reconstruction. Ann Thorac Surg. 2018 June ; 105(6): 1809–1818.
4. Evaluation of Gamma Irradiated and Limited Donor Pool Human Platelet Lysate for Clinical Cell Manufacturing. ISCT Poster Presentation, Montreal, 2018
5. Cost Effectiveness Analysis of Just-In-Time Expansion of Mesenchymal Stem/Stromal Cells (MSCs) With PLUS™ Human Platelet Lysate For an Allogeneic Clinical Trial. ISCT Poster Presentation, Montreal, 2018
6. Cost Effectiveness Analysis of Expansion of Bone Marrow Mesenchymal Stem Cells and Adipose Stem Cells With PLUS™ Human Platelet Lysate. Cell and Gene Therapy Bioprocessing and Commercialization Poster Presentation, Boston, 2017
7. Irradiation Methods for Pathogen Reduction of Xeno-Free Human Platelet Lysate. ISCT Poster Presentation, London, 2017
8. Co-administration of First Trimester Umbilical Cord-Derived Perivascular Cells (FTM HUCPVCs) with Endothelial Progenitor Cells (EPCs) Leads to Enhanced Angiogenesis, both in vitro and in vivo, Compared to either Cell Type alone. ISCT Poster Presentation by Create Fertility Centre, London, 2017
9. Generation of Monocyte Derived Dendritic Cells Using Xeno-Free Clinical Grade Human Platelet Lysate. ISCT Poster Presentation, Memphis, 2016
10. Human Platelet Lysate (hPL) is Optimal for Expansion of First Trimester Human Umbilical Cord Perivascular Cells for Regenerative Medicine Applications. Canadian Fertility and Andrology Society Poster Presentation, Toronto, 2016
11. Evaluation of Tissue Homogenization to Support the Generation of GMP-Compliant Mesenchymal Stromal Cells from the Umbilical Cord. Stem Cells International, vol. 2016, Article ID 3274054, 9 pages, 2016
12. Human Platelet Lysate Produced at Industrial Scale for use as Fetal Bovine Serum Replacement in MSC Cell Therapies. MSC Poster Presentation, Cleveland, 2015
13. Human Platelet Lysate Enhances Wound Healing. MHSRS Poster Presentation, Ft. Lauderdale, 2015
14. Human Platelet Lysate Produced at Industrial Scale for Use as Fetal Bovine Serum Replacement in Cell Manufacturing Protocols. ISCT Poster Presentation, Las Vegas, 2015
15. Human Platelet Lysate as a Cell Culture Media Supplement in Conjunction with a Cryoprecipitate-Coated Bioreactor for the Expansion of Human Mesenchymal Stem Cells in the Quantum System. ISSCR Poster Presentation by Terumo BCT, Vancouver, 2014                   
16. Clinical-Grade Human Platelet Lysate Produced at Industrial Scale for Isolation, Expansion, and Cryopreservation of Mesenchymal Stromal Cells. ISSCR Poster Presentation, Vancouver, 2014                      
17. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther. 3(1); 6 (2012)
18. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion. 24(8); 1436-1446 (2007)
19. Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow. Stem Cells. 27(9); 2331-41 (2009)​